Derin B. Keskin - Concepedia

Author

Derin B. Keskin

Also Known As

D B Keskin, D Keskin, D. B. Keskin, Derin B Keskin, Derin B. KESKIN, Derin B. Keskin, Derin Benerci Keskin, Derin Keskin, Derin B. Keskin, Derin B. Keskin

269

Publications

14.3K

Citations

H-Index

123

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Broad Institute Brigham and Women's Hospital Massachusetts General Hospital

About

Derin B. Keskin is an author at Dana-Farber Cancer Institute specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	38	10.4K
2	Allergy	5	5	480
3	Engineering	4	4	199
4	Natural Sciences	2	2	90
5	Biochemistry	2	2	78

Derin B. Keskin

Publications

13.1K

Citations

H-Index

Page 1

	Year	Citations
An immunogenic personal neoantigen vaccine for patients with melanoma Patrick A. Ott, Zhuting Hu, Derin B. Keskin, Nature VaccinationTumor ImmunologyMelanomaImmunologyTherapeutic Vaccine	2017	2.8K
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial Derin B. Keskin, Annabelle Anandappa, Jing Sun, Nature Neuro-oncologyTumor ImmunologyCancer ImmunosurveillanceGliomaImmunology	2018	1.4K
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase David H. Munn, Madhav Sharma, Jeffrey R. Lee, Science Human ApcsPotential Regulatory FunctionDendritic CellAdaptive Immune SystemImmunology	2002	1K
Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction Jennifer G. Abelin, Derin B. Keskin, Siranush Sarkizova, Immunity HistocompatibilityHlaSystems BiologyAutoimmune DiseaseHuman Leukocyte Antigen	2017	630
A large peptidome dataset improves HLA class I epitope prediction across most of the human population Siranush Sarkizova, Susan Klaeger, Phuong M. Le, Nature Biotechnology HlaHistocompatibilityImmunogeneticsAutoimmune DiseaseHuman Leukocyte Antigen	2019	511
Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma Giacomo Oliveira, Kari Stromhaug, Susan Klaeger, Nature Cancer ImmunosurveillanceMelanomaImmunologyAutoimmunityImmunotherapy	2021	508
Progressive immune dysfunction with advancing disease stage in renal cell carcinoma David A. Braun, Kelly Street, Kelly P. Burke, Cancer Cell Progressive Immune DysfunctionUrologyCancer ImmunosurveillanceGenitourinary CancerMedicine	2021	483
Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma Zhuting Hu, Donna Leet, Rosa Lundbye Allesøe, Nature Medicine VaccinationTumor ImmunologyEpitope SpreadingCancer ImmunosurveillancePersonal Neoantigen Vaccines	2021	482
TGFβ promotes conversion of CD16 <sup>+</sup> peripheral blood NK cells into CD16 <sup>−</sup> NK cells with similarities to decidual NK cells Derin B. Keskin, David Allan, Basya Rybalov, Proceedings of the National Academy of Sciences	2007	357
Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies Romain Guièze, Vivian M. Liu, Daniel Rosebrock, Cancer Cell Lymphoid NeoplasiaMitochondrial FunctionMedicineMalignant Blood DisorderImmunology	2019	348

Page 1